The neuroprotective marine compound psammaplysene A binds the RNA-binding protein HNRNPK

10Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

In previous work, we characterized the strong neuroprotective properties of the marine compound Psammaplysene A (PA) in in vitro and in vivo models of neurodegeneration. Based on its strong neuroprotective activity, the current work attempts to identify the physical target of PA to gain mechanistic insight into its molecular action. Two distinct methods, used in parallel, to purify protein-binding partners of PA led to the identification of HNRNPK as a direct target of PA. Based on surface plasmon resonance, we find that the binding of PA to HNRNPK is RNA-dependent. These findings suggest a role for HNRNPK-dependent processes in neurodegeneration/neuroprotection, and warrant further study of HNRNPK in this context.

Cite

CITATION STYLE

APA

Boccitto, M., Lee, N., Sakamoto, S., Spruce, L. A., Handa, H., Clardy, J., … Kalb, R. G. (2017). The neuroprotective marine compound psammaplysene A binds the RNA-binding protein HNRNPK. Marine Drugs, 15(8). https://doi.org/10.3390/md15080246

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free